IL-4/IL-13单抗Dupixent-话题@MedSci

#IL-4/IL-13单抗Dupixent#

4篇内容 | 742人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1477308, encodeId=61f914e730871, content=<a href='/topic/show?id=c5d796e31e' target=_blank style='color:#2F92EE;'>#IL-4/IL-13单抗Dupixent#</a>, objectTitle=赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作, objectType=article, longId=202084, objectId=58c820208475, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58c820208475, replyNumber=0, likeNumber=44, createdTime=2020-10-15, rootId=0, userName=ms5822920152752585, userId=83677370380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58c820208475, moduleTitle=赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58c820208475)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477307, encodeId=d41314e730734, content=<a href='/topic/show?id=c5d796e31e' target=_blank style='color:#2F92EE;'>#IL-4/IL-13单抗Dupixent#</a>, objectTitle=IL-4/IL-13单抗DUPIXENT获得INESSS的积极推荐，用于治疗中度至重度特应性皮炎, objectType=article, longId=197603, objectId=36c019e60339, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36c019e60339, replyNumber=0, likeNumber=38, createdTime=2020-07-17, rootId=0, userName=ms5822920152752585, userId=83677370380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36c019e60339, moduleTitle=IL-4/IL-13单抗DUPIXENT获得INESSS的积极推荐，用于治疗中度至重度特应性皮炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36c019e60339)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477306, encodeId=b75714e7306c4, content=<a href='/topic/show?id=c5d796e31e' target=_blank style='color:#2F92EE;'>#IL-4/IL-13单抗Dupixent#</a>, objectTitle=赛诺菲的IL-4/IL-13单抗Dupixent，在特应性皮炎儿童患者中显示出明显益处, objectType=article, longId=191379, objectId=18d21913e93a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18d21913e93a, replyNumber=0, likeNumber=44, createdTime=2020-04-05, rootId=0, userName=ms5822920152752585, userId=83677370380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18d21913e93a, moduleTitle=赛诺菲的IL-4/IL-13单抗Dupixent，在特应性皮炎儿童患者中显示出明显益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=18d21913e93a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1477305, encodeId=1bd514e730566, content=<a href='/topic/show?id=c5d796e31e' target=_blank style='color:#2F92EE;'>#IL-4/IL-13单抗Dupixent#</a>, objectTitle=FDA批准将赛诺菲/再生元的IL-4/IL-13单抗Dupixent用于治疗鼻息肉, objectType=article, longId=174393, objectId=fc561e4393b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc561e4393b5, replyNumber=0, likeNumber=44, createdTime=2019-06-29, rootId=0, userName=ms5822920152752585, userId=83677370380, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc561e4393b5, moduleTitle=FDA批准将赛诺菲/再生元的IL-4/IL-13单抗Dupixent用于治疗鼻息肉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc561e4393b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IL-4/IL-13单抗Dupixent

2020-05-29

ms5822920152752585 (审核中...)

前往app查看评论内容

#IL-4/IL-13单抗Dupixent#

赛诺菲的IL-4/IL-13单抗Dupixent显著减轻儿童的严重哮喘发作

2020-10-15

ms5822920152752585 (审核中...)

前往app查看评论内容

#IL-4/IL-13单抗Dupixent#

IL-4/IL-13单抗DUPIXENT获得INESSS的积极推荐，用于治疗中度至重度特应性皮炎

2020-07-17

ms5822920152752585 (审核中...)

前往app查看评论内容

#IL-4/IL-13单抗Dupixent#

赛诺菲的IL-4/IL-13单抗Dupixent，在特应性皮炎儿童患者中显示出明显益处

2020-04-05

ms5822920152752585 (审核中...)

前往app查看评论内容

#IL-4/IL-13单抗Dupixent#

FDA批准将赛诺菲/再生元的IL-4/IL-13单抗Dupixent用于治疗鼻息肉

2019-06-29

科室
- - 订阅+
  - 更多科室
工具
服务